These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysis. Coleman CI, Bunz TJ, Eriksson D, Meinecke AK, Sood NA. Diabet Med; 2018 Aug; 35(8):1105-1110. PubMed ID: 29663521 [Abstract] [Full Text] [Related]
24. Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin. Huang HK, Liu PP, Hsu JY, Lin SM, Peng CC, Wang JH, Yeh JI, Loh CH. J Am Heart Assoc; 2020 Jan 21; 9(2):e013845. PubMed ID: 31918601 [Abstract] [Full Text] [Related]
25. Direct Comparison of the Effectiveness and Safety Among Direct Oral Anticoagulants and Warfarin in Japanese Patients: Nationwide Cohort Study in Japan. Katayama S, Aoki Y, Akita A, Satake R, Tohkin M. Clin Pharmacol Ther; 2024 Oct 21; 116(4):1023-1033. PubMed ID: 38818726 [Abstract] [Full Text] [Related]
29. Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system. Villines TC, Ahmad A, Petrini M, Tang W, Evans A, Rush T, Thompson D, Oh K, Schwartzman E. Eur Heart J Cardiovasc Pharmacother; 2019 Apr 01; 5(2):80-90. PubMed ID: 30500885 [Abstract] [Full Text] [Related]
30. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis. See LC, Lee HF, Chao TF, Li PR, Liu JR, Wu LS, Chang SH, Yeh YH, Kuo CT, Chan YH, Lip GYH. Cardiovasc Drugs Ther; 2021 Oct 01; 35(5):975-986. PubMed ID: 33211254 [Abstract] [Full Text] [Related]
34. Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data. Costa OS, Beyer-Westendorf J, Ashton V, Milentijevic D, Moore KT, Bunz TJ, Coleman CI. Curr Med Res Opin; 2020 Jul 01; 36(7):1081-1088. PubMed ID: 32347755 [Abstract] [Full Text] [Related]
35. Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia. Rockhold M, Kunkel L, Lacoste JL, Szymanski T, Rothenberg P, Zimmerman P, Minc S. J Vasc Surg; 2024 Jun 01; 79(6):1466-1472.e1. PubMed ID: 38278371 [Abstract] [Full Text] [Related]
38. Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data. Di Lullo L, Tripepi G, Ronco C, De Pascalis A, Barbera V, Granata A, Russo D, Di Iorio BR, Paoletti E, Ravera M, Fusaro M, Bellasi A. J Nephrol; 2018 Oct 01; 31(5):751-756. PubMed ID: 29882198 [Abstract] [Full Text] [Related]